aTyr Pharma, Inc. (ATYR)
0.8939
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
0.8975
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma EPS Diluted (Quarterly) : -0.265 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | -2.160 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.75M |
| Revenue (Quarterly) | 0.19M |
| Total Expenses (Quarterly) | 25.93M |
| Enterprise Value | 9.556M |
| Gross Profit Margin (Quarterly) | -104.7% |
| Profit Margin (Quarterly) | -13.55K% |
| Earnings Yield | -93.37% |
| Normalized Earnings Yield | -93.38 |